Indian digital healthcare platform PharmEasy filed for an initial public offering (IPO) on Wednesday of up to 62.50 billion rupees ($842.43 million), becoming the latest start-up in the country to pursue a domestic stock listing.
API Holdings Ltd, PharmEasy's parent, may also consider a further issue of equity shares via a private placement of up to 12.50 billion rupees, the company said in its draft red herring prospectus.